OpenSAFELY
Reports

Vaccine Coverage

Description
Weekly* report on COVID-19 vaccination coverage in England, based on the population of 23.4m people registered with practices that use TPP SystmOne software. * please note, updates will occur most weeks but not all.
Contact
Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
First published
22 Dec 2020
Last updated
27 Oct 2021
Links

OpenSAFELY COVID Vaccine coverage report

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of January 13th) in our preprint paper available here.

The full analytical methods behind the latest results in this report are available here.

Report last updated 25 Oct 2021

Vaccinations included up to 21 Oct 2021 inclusive

Contents:

Overview of Vaccination Figures to date

first dose as at 21 Oct 2021 second dose as at 21 Oct 2021 third dose as at 21 Oct 2021
Group
Total vaccinated in TPP 16,289,665 15,250,634 1,737,596
80+ 96.6% (1,037,358 of 1,074,360) 95.4% (1,025,346 of 1,074,360) 51.5% (553,679 of 1,074,360)
70-79 96.0% (1,980,083 of 2,062,081) 95.1% (1,960,273 of 2,062,081) 23.1% (476,126 of 2,062,081)
care home 96.2% (85,372 of 88,781) 93.0% (82,537 of 88,781) 36.4% (32,298 of 88,781)
shielding (aged 16-69) 91.0% (764,736 of 840,084) 87.9% (738,444 of 840,084) 11.8% (99,148 of 840,084)
65-69 93.5% (1,005,956 of 1,075,739) 92.4% (993,615 of 1,075,739) 6.0% (64,190 of 1,075,739)
LD (aged 16-64) 87.3% (73,346 of 83,993) 82.6% (69,349 of 83,993) 2.7% (2,289 of 83,993)
60-64 91.8% (1,178,485 of 1,283,674) 90.4% (1,159,865 of 1,283,674) 6.4% (82,663 of 1,283,674)
55-59 90.0% (1,369,207 of 1,521,191) 88.2% (1,341,375 of 1,521,191) 6.6% (100,107 of 1,521,191)
50-54 87.8% (1,382,227 of 1,574,706) 85.5% (1,345,918 of 1,574,706) 6.0% (94,073 of 1,574,706)
40-49 80.4% (2,394,273 of 2,977,870) 76.7% (2,282,700 of 2,977,870) 3.7% (109,130 of 2,977,870)
30-39 70.2% (2,355,703 of 3,357,879) 64.0% (2,147,558 of 3,357,879) 2.3% (76,174 of 3,357,879)
18-29 67.0% (2,353,477 of 3,511,935) 57.2% (2,009,378 of 3,511,935) 1.3% (47,166 of 3,511,935)
16-17 58.8% (309,442 of 526,204) 17.9% (94,262 of 526,204) 0.1% (546 of 526,204)

NB Patient counts are rounded to nearest 7

Second doses are at least 19 days after the first; third doses at least 8 weeks after the second

Group definitions

  • The care home group is defined based on patients (aged 65+) having one of these codes.

  • The shielding group is defined based on patients having one of these codes provided it was not superceded by one of these codes.

  • The LD (learning disability) group is defined based on this codelist and excludes people who are shielding.

  • Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 population

Vaccine types

Note: numbers may not sum to 100% as it is not always possible to determine vaccine type given, and patients occasionally have more than one brand recorded on the same day.

Oxford-AZ vaccines (% of all first doses): 51.7% (8,414,574)

Pfizer vaccines (% of all first doses): 45.9% (7,473,893)

Moderna vaccines (% of all first doses): 2.5% (405,251)

Second doses and dose combinations

Note: second dose figures are raw proportions and do not take into account how many are due, which is likely to vary substantially by brand.
For more detailed analysis please refer to our second dose report

Second doses (% of all vaccinated): 93.6% (15,250,634)

Second doses (% of Ox-AZ first doses): 97.7% (8,218,973)

Second doses (% of Pfizer first doses): 89.4% (6,684,048)

Second doses (% of Moderna first doses): 87.1% (353,010)


Note: mixed doses counts patients with first and second doses at least 19 days apart, excluding patients with two different brands recorded on the same day or recorded on a date prior to when the given brand was available in the UK

Mixed doses Ox-AZ + Pfizer (% of fully vaccinated): 0.3% (44814)

Mixed doses Ox-AZ + Moderna (% of fully vaccinated): 0.0% (2121)

Mixed doses Moderna + Pfizer (% of fully vaccinated): 0.0% (3514)

Summary Charts

Note: 'Priority groups' only includes those identified as being in a priority group by our methodology. 'Others' includes everyone aged 18-49 except those who are shielding or have a learning disability.

Trends in vaccination rates of 80+ population according to demographic/clinical features, cumulatively by day.

*Latest overall cohort rate calculated as at latest date for vaccinations recorded across all TPP practices.

80+ population

COVID vaccinations among 80+ population

by Sex

COVID vaccinations among 80+ population

by Ethnicity (broad categories)

COVID vaccinations among 80+ population

by Index of Multiple Deprivation (quintiles)

COVID vaccinations among 80+ population

by BMI